Association of Project ECHO Training With Buprenorphine Prescribing by Primary Care Clinicians in Minnesota for Treating Opioid Use Disorder

IMPORTANCE: Buprenorphine is an approved medication for opioid use disorder (MOUD); however, prescribing buprenorphine is limited by a requirement to obtain a waiver to prescribe it (hereinafter, “DATA [Drug Abuse Treatment Act]–waiver”) and a lack of knowledge of the best practices among clinicians...

Descripción completa

Detalles Bibliográficos
Autores principales: Solmeyer, Anna R., Berger, Aaron T., Barton, Sean L., Nguyen, Benjamin, Bart, Gavin B., Grahan, Brian, Bell, Heather J., DeVine, Kurt M., Merrick, Weston
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675001/
https://www.ncbi.nlm.nih.gov/pubmed/36399352
http://dx.doi.org/10.1001/jamahealthforum.2022.4149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675001/
https://www.ncbi.nlm.nih.gov/pubmed/36399352
http://dx.doi.org/10.1001/jamahealthforum.2022.4149

Ejemplares similares